ライフサイエンスコーパス: embolus

1 ad cycle 1 dose-limiting toxicity (pulmonary embolus).

2 thmia, symptomatic hypotension, or pulmonary embolus).

3 osis type (deep vein thrombosis or pulmonary embolus).

4 ients (17%) had a possible cardiac source of embolus.

5 and 1 eventually developed a major pulmonary embolus.

6 age younger than 65 years and no more than 1 embolus.

7 n conduit/right atrial thrombus or pulmonary embolus.

8 No patient developed a pulmonary embolus.

9 and its 360 degrees distribution around the embolus.

10 ent as a result of an asymptomatic pulmonary embolus.

11 leak, small bowel obstruction, and pulmonary embolus.

12 during treatment as a result of a pulmonary embolus.

13 cyst and accounts for the compactness of the embolus.

14 3% of patients having a stroke or peripheral embolus.

15 ent required surgery for a delayed popliteal embolus.

16 echniques permit direct visualization of the embolus.

17 cause serious conditions due to paradoxical embolus.

18 gnant patients suspected of having pulmonary embolus.

19 ient ischemic attack, and 1 had a peripheral embolus.

20 as a result of sepsis and one of a pulmonary embolus.

21 g on the discrimination between contrast and embolus.

22 One death occurred related to a pulmonary embolus (0.4%).

23 fic diseases, RRs were as follows: pulmonary embolus 1.87 (95% CI 1.13-3.07, p=0.01 [including 0.2% m

24 Grade 4 adverse events included pulmonary embolus (1), vomiting and constipation (1), and proteinu

25 ndrome (8.0% vs 9.2% vs 15.8%), or pulmonary embolus (1.9% vs 2.4% vs 6.8%) and to require intubation

26 common serious adverse events were pulmonary embolus (11 [1.6%] in the albumin group vs 8 [1.2%] in t

27 cerning CTPE findings: (1) bilateral central embolus, (2) right ventricle-to-left ventricle ratio gre

28 mA; 0.35-second tube rotation) and pulmonary embolus (64 sections at 1.25 mm, 140 kVp, 645 mA, 0.5-se

29 tients, V-P scintigrams predicted unilateral embolus; 64 patients underwent pulmonary angiography of

30 the proportion of patients with new cerebral embolus after TAVR and to investigate whether parenteral

31 (VTE) (deep venous thrombosis and pulmonary embolus) after splenectomy was 4.3% compared with 1.7% i

32 Two patients had a pulmonary embolus and four had Greenfield filters in the remote pa

33 n thrombosis but a reduced rate of pulmonary embolus and heparin-induced thrombocytopenia among criti

34 ings were driven by lower rates of pulmonary embolus and heparin-induced thrombocytopenia and corresp

35 enerates the formation of the lymphovascular embolus and is responsible for its unique properties of

36 le-out' for myocardial infarction, pulmonary embolus, and aortic dissection, with an eye to improving

37 , sequelae of gastric perforation, pulmonary embolus, and disease progression.

38 Chest pain, pulmonary embolus, and mental status change cases posed the greate

39 ombus, ischemic stroke, or systemic arterial embolus; and nonsystemic TEC, defined as Fontan conduit/

40 Patients with amniotic fluid embolus are best managed using a multidisciplinary appro

41 nique properties of the lymphovascular tumor embolus are poorly understood largely because of the abs

42 iagnosis in 15 cases, with the most proximal embolus at the segmental level in four cases and at the

43 re calculated for each MR technique on a per-embolus basis, and 95% confidence intervals were calcula

44 Embolus detection rates were lowest in the lingula branc

45 evaluation, daily transcranial Doppler with embolus detection studies, and neurological examinations

46 l charts were reviewed for demographic data, embolus detection, and outcomes up to 2 years after the

47 in silico trials to relate lesion volume to embolus diameter and calculate probabilistic lesion over

48 e including 3D information, identifying that embolus diameter could be determined from infarct volume

49 r law relationship between lesion volume and embolus diameter was found.

50 lpha2-antiplasmin inactivation, causing more embolus dissolution than clinical-dose r-tPA alone (P<0.

51 ditionally, we demonstrate how the resulting embolus distribution patterns compare and correlate with

52 mbosis not otherwise specified, or pulmonary embolus during the study period, and who had been treate

53 silico model can generate deep insights into embolus dynamics which is not otherwise available from s

54 However, within the lymphovascular embolus, E-cad and its proteolytic processing by calpain

55 The rate of embolus extravasation was significantly decreased by pha

56 We use a patient-specific computational embolus-hemodynamics interaction model developed in prio

57 Using the concepts of size-dependent embolus-hemodynamics interactions, and jet impingement d

58 was complicated by another saddle pulmonary embolus, heparin-induced thrombocytopenia, and COVID-19

59 us studies, demonstrated that the tumor cell embolus (IBC spheroid) forms on the basis of an intact a

60 roaches (H-2K(d)-E-cad), that the tumor cell embolus (IBC spheroid) forms on the basis of an intact a

61 The tumor cell embolus (IBC spheroid), in contrast, fails to bind the s

62 umonia in 21, Hemothorax in 12 and pulmonary embolus in 8.Median/5-year survival were 20.7 months/17.

63 Evidence of an embolus in a main pulmonary or lobar artery or evidence

64 ne death despite treatment and one recurrent embolus in a nontreated patient.

65 an extra breast cancer,stroke, or pulmonary embolus in about 6 per 1000 users aged 50-59 and 12 per

66 and non-lethal means to assess for pulmonary embolus in the non-human primate.

67 nt expired as a result of an acute pulmonary embolus in the setting of bilateral hip fractures.

68 The MCA was occluded by an embolus in Wistar rats (n = 71).

69 intracranial haemorrhages, and one systemic embolus) in people assigned to warfarin and 48 primary e

70 e of infection, venous thrombosis, pulmonary embolus, inability to aspirate blood, mechanical failure

71 The lymphovascular tumor embolus is a blastocyst-like structure resistant to chem

72 xcellent for diameter (k = 0.981) and tumour embolus (k = 0.927).

73 e, comorbidity, and surgical risk (pulmonary embolus, leak, death, incisional hernia) than in other p

74 mproved understanding of embolic events, and embolus movement to the brain, is critical to develop te

75 s were limited to clinically unimportant air embolus (n = 2).

76 of platelet accumulation at the site of the embolus occluding the MCA and within downstream cerebral

77 in PAI-1 immunoreactivity at the site of the embolus occluding the MCA were detected 1 h (n=7) and 4

78 were subjected to variable MCAO by suture or embolus occlusion.

79 Pulmonary embolus {odds ratio [OR] 12.34 [95% confidence interval

80 ression in the genesis of the lymphovascular embolus of IBC.

81 o received tofersen, one died from pulmonary embolus on day 137, and one from respiratory failure on

82 ations OR 0.72 (95% CI 0.55-0.93), pulmonary embolus OR 0.29 (95% CI 0.11-0.73), pneumonia OR 0.66 (9

83 or laceration (APL), postoperative pulmonary embolus or deep venous thrombosis (PEDVT), foreign body

84 farction, peripheral or pulmonary thrombosis/embolus, or heart failure.

85 ncluding TNM staging, metastasis, and cancer embolus; Overall, this study suggested that tagSNPs rs11

86 roke, transient ischemic attack, or systemic embolus (p = 0.014) were positive predictors of warfarin

87 n thrombosis (DVT) alone in 49.7%, pulmonary embolus (PE) alone in 25.4%, DVT plus PE in 13.6%, arter

88 Pulmonary embolus (PE) was identified in 44 recipients (incidence,

89 nterpretation algorithms for acute pulmonary embolus (PE).

90 xtender rounds reduces the risk of pulmonary embolus, pneumonia, and death when compared to chart doc

91 e adverse events (including death, pulmonary embolus, pneumonia, deep wound infection, and acute myoc

92 clinical scenarios: postoperative pulmonary embolus, pneumothorax, myocardial infarction, gastrointe

93 perioperative death included leak, pulmonary embolus, preoperative weight, and hypertension.

94 dies examined deep vein thrombosis/pulmonary embolus prevention (42%) or venous ulceration (25%).

95 The Multi Mechanical Embolus Removal in Cerebral Ischemia trial showed that g

96 of detached biofilm particles depends on the embolus size and could be attributed to nutrient-limited

97 rived for each set of images on the basis of embolus size and location.

98 d be determined from infarct volume and that embolus size is critically important to the resting plac

99 3 days after surgery, following a pulmonary embolus (spleen weight 500 g, mortality 1/108, 0.9%).

100 Major complications (reintubation, pulmonary embolus, stroke, renal failure, coma, cardiac arrest, my

101 allows more confident detection of pulmonary embolus than does CFA, with no loss in diagnostic accura

102 culty with rapidly adequately diagnosing the embolus, the lack of good data supporting the use of thr

103 bedside echocardiogram suggesting pulmonary embolus, thrombolytic therapy was administered during ca

104 nd the apparent lack of binding of the tumor embolus to the surrounding endothelium.

105 Iodine-123-bitistatin had embolus-to-blood ratios averaging 27 +/- 7, which was hi

106 ined) were cellulitis (two cases), pulmonary embolus (two cases), and deep-vein thrombosis (three cas

107 oses (acute myocardial infarction, pulmonary embolus, upper gastrointestinal bleed), and comorbiditie

108 lopment of deep vein thrombosis or pulmonary embolus (venous thromboembolism [VTE]).

109 Pulmonary embolus was diagnosed in 357 patients (24.9%).

110 An embolus was found in all rats at 24 h after embolization

111 Pulmonary embolus was not suspected at CT in the remaining 18 pati

112 gnant patients suspected of having pulmonary embolus, with considerable variability in their policies